The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis
Deborah Assayag(University of California, San Francisco), Harold R. Collard(University of California, San Francisco), Laura L. Koth(University of California, San Francisco), Xiaowen Hu(Lanzhou University), Elisabetta Cocconcelli(University of Modena and Reggio Emilia), Christopher J. Ryerson(University of British Columbia), Paul J. Wolters(University of California, San Francisco), Eric Vittinghoff(University of California, San Francisco), Kirk D. Jones, Brett M. Elicker, Roberto Tonelli(University of Modena and Reggio Emilia), Talmadge E. King(University of California, San Francisco), Jay H. Ryu(Mayo Clinic), Anthony K. Shum(University of California, San Francisco), Jeffrey A. Golden(University of California, San Francisco), Joyce Lee(Inserm), Brett Ley(University of California, San Francisco)
Cited by 12
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k